These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 32186222)
1. Plexin-B2 in psoriasis; a clinical and immunohistochemical study. Hemida AS; Mareae AH; Elbasiony ASA; Shehata WA J Immunoassay Immunochem; 2020 Jul; 41(4):718-728. PubMed ID: 32186222 [TBL] [Abstract][Full Text] [Related]
2. Plexin B2 tissue expression and related gene polymorphisms in psoriasis and their relation to NB-UVB and Acitretin therapy. Hegazy EM; Taieb MAE; Hassan MH; Ibrahim AK; El-Din EA; Ibrahim HM Arch Dermatol Res; 2024 May; 316(5):162. PubMed ID: 38734848 [TBL] [Abstract][Full Text] [Related]
3. Progranulin and beta-catenin in psoriasis: An immunohistochemical study. Farag AGA; Shoaib MA; Samaka RM; Abdou AG; Mandour MM; Ibrahim RAL J Cosmet Dermatol; 2019 Dec; 18(6):2019-2026. PubMed ID: 31091001 [TBL] [Abstract][Full Text] [Related]
4. Role of CYR61 in psoriatic lesional and perilesional skin: A clinical and immunohistochemical study. Shehata WA; Maraee AH; Abdo EE; Hemida AS J Cosmet Dermatol; 2021 Sep; 20(9):2981-2988. PubMed ID: 33484099 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of cornulin in lesional and perilesional skin of plaque psoriasis. Shehata WA; Hammam MA; Ayad A; Holah NS J Cosmet Dermatol; 2022 Aug; 21(8):3537-3545. PubMed ID: 34859561 [TBL] [Abstract][Full Text] [Related]
6. Smad7 in psoriasis vulgaris patients: A clinical and immunohistochemical study. Hemida AS; Hammam MA; Salman ATA; Shehata WA J Cosmet Dermatol; 2020 Dec; 19(12):3395-3402. PubMed ID: 32307790 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of janus kinase 1/signal transducer and activator of transcription 3 in psoriasis vulgaris. Farag AGA; Samaka R; Elshafey EN; Shehata WA; El Sherbiny EG; Hammam MA Clin Cosmet Investig Dermatol; 2019; 12():497-508. PubMed ID: 31308720 [No Abstract] [Full Text] [Related]
9. Negative regulation of dendritic cell activation in psoriasis mediated via CD100-plexin-B2. Xiao C; Luo Y; Zhang C; Zhu Z; Yang L; Qiao H; Fu M; Wang G; Yao X; Li W J Pathol; 2020 Apr; 250(4):409-419. PubMed ID: 31943215 [TBL] [Abstract][Full Text] [Related]
10. Light chain 3 immunoexpression in psoriasis. Samaka RM; Marae A; Faried M; Bazid HAS J Immunoassay Immunochem; 2022 Jul; 43(4):365-383. PubMed ID: 34996338 [TBL] [Abstract][Full Text] [Related]
11. Nuclear factor kappa B and cyclo-oxygenase-2: two concordant players in psoriasis pathogenesis. Bakry OA; Samaka RM; Shoeib MA; Abdel Aal SM Ultrastruct Pathol; 2015 Feb; 39(1):49-61. PubMed ID: 25215902 [TBL] [Abstract][Full Text] [Related]
12. Osteopontin expression in chronic plaque psoriasis: an association with the severity of disease. Abdou AG; El Farargy S; Seleit I; Antar AG; Elhefny M; Elnaidany NF Anal Quant Cytol Histol; 2012 Apr; 34(2):79-85. PubMed ID: 22611763 [TBL] [Abstract][Full Text] [Related]
13. CD100-Plexin-B2 Promotes the Inflammation in Psoriasis by Activating NF-κB and the Inflammasome in Keratinocytes. Zhang C; Xiao C; Dang E; Cao J; Zhu Z; Fu M; Yao X; Liu Y; Jin B; Wang G; Li W J Invest Dermatol; 2018 Feb; 138(2):375-383. PubMed ID: 28927892 [TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 levels are increased in sera and lesional skin extracts of psoriatic patients and correlate with disease severity. Bonifati C; Mussi A; Carducci M; Pittarello A; D'Auria L; Venuti A; Bagnato A; Salani D; Fazio M; Ameglio F Acta Derm Venereol; 1998 Jan; 78(1):22-6. PubMed ID: 9498021 [TBL] [Abstract][Full Text] [Related]
15. Dimethylfumarate for psoriasis: Pronounced effects on lesional T-cell subsets, epidermal proliferation and differentiation, but not on natural killer T cells in immunohistochemical study. Bovenschen HJ; Langewouters AM; van de Kerkhof PC Am J Clin Dermatol; 2010; 11(5):343-50. PubMed ID: 20553063 [TBL] [Abstract][Full Text] [Related]
16. Granulysin expression increases with increasing clinical severity of psoriasis. Elgarhy LH; Shareef MM; Moustafa SM Clin Exp Dermatol; 2015 Jun; 40(4):361-6. PubMed ID: 25639185 [TBL] [Abstract][Full Text] [Related]
17. Perforin expression in plaque psoriasis: an immunohistochemical study. Samaka RM; Gaber MA; Metwe NA Ultrastruct Pathol; 2015 Apr; 39(2):110-20. PubMed ID: 25222509 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of TRAIL and its death receptors DR4 and DR5 in plaque psoriasis. Peternel S; Prpić-Massari L; Manestar-Blažić T; Brajac I; Kaštelan M Arch Dermatol Res; 2011 Aug; 303(6):389-97. PubMed ID: 21279373 [TBL] [Abstract][Full Text] [Related]
19. Balance of Treg vs. T-helper cells in the transition from symptomless to lesional psoriatic skin. Keijsers RR; van der Velden HM; van Erp PE; de Boer-van Huizen RT; Joosten I; Koenen HJ; van de Kerkhof PC Br J Dermatol; 2013 Jun; 168(6):1294-302. PubMed ID: 23330679 [TBL] [Abstract][Full Text] [Related]
20. Angiogenesis in psoriatic skin and its modifications after administration of etanercept: videocapillaroscopic, histological and immunohistochemical evaluation. Campanati A; Goteri G; Simonetti O; Ganzetti G; Giuliodori K; Giuliano A; Sabato S; Stramazzotti D; Gulini E; Dusi D; De Blasio S; Fabris G; Offidani A Int J Immunopathol Pharmacol; 2009; 22(2):371-7. PubMed ID: 19505391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]